These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32049156)

  • 1. Safety of Catheter Ablation of Atrial Fibrillation Under Uninterrupted Rivaroxaban Use.
    Silva MA; Futuro GMC; Merçon ES; Vasconcelos D; Agrizzi RS; Elias Neto J; Kuniyoshi R
    Arq Bras Cardiol; 2020 Mar; 114(3):435-442. PubMed ID: 32049156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin.
    Tao S; Otomo K; Ono Y; Osaka Y; Hirao T; Koura K; Manno T; Ueshima D; Shimizu S; Isobe M; Hirao K
    J Interv Card Electrophysiol; 2017 Mar; 48(2):167-175. PubMed ID: 27943112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
    J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of different anticoagulation therapies on heparin dosage applied to atrial fibrillation patients undergoing atrial fibrillation catheter ablation].
    Yang L; Gao LJ; Yin XM; Guo BL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Aug; 47(8):602-607. PubMed ID: 31434430
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL; Lindsley JP; Moranville MP; Habibi M; Khurram IM; Spragg DD; Berger RD; Calkins H; Marine JE
    Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.
    Cappato R; Marchlinski FE; Hohnloser SH; Naccarelli GV; Xiang J; Wilber DJ; Ma CS; Hess S; Wells DS; Juang G; Vijgen J; Hügl BJ; Balasubramaniam R; De Chillou C; Davies DW; Fields LE; Natale A;
    Eur Heart J; 2015 Jul; 36(28):1805-11. PubMed ID: 25975659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation.
    Naccarelli GV; Cappato R; Hohnloser SH; Marchlinski FE; Wilber DJ; Xiang J; Ma C; Hess S; Davies DW; Fields LE; Natale A;
    J Interv Card Electrophysiol; 2014 Nov; 41(2):107-16. PubMed ID: 25005452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin.
    Shin DG; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN
    Yonsei Med J; 2016 Mar; 57(2):342-9. PubMed ID: 26847285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study.
    Di Biase L; Lakkireddy D; Trivedi C; Deneke T; Martinek M; Mohanty S; Mohanty P; Prakash S; Bai R; Reddy M; Gianni C; Horton R; Bailey S; Sigmund E; Derndorfer M; Schade A; Mueller P; Szoelloes A; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Hongo RH; Beheiry S; Pürerfellner H; Burkhardt JD; Natale A
    Heart Rhythm; 2015 Jun; 12(6):1162-8. PubMed ID: 25728754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic Cerebral Infarction During Catheter Ablation for Atrial Fibrillation: Comparing Uninterrupted Rivaroxaban and Warfarin (ASCERTAIN).
    Kimura T; Kashimura S; Nishiyama T; Katsumata Y; Inagawa K; Ikegami Y; Nishiyama N; Fukumoto K; Tanimoto Y; Aizawa Y; Tanimoto K; Fukuda K; Takatsuki S
    JACC Clin Electrophysiol; 2018 Dec; 4(12):1598-1609. PubMed ID: 30573125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban.
    Tsyganov A; Shapieva A; Sandrikov V; Fedulova S; Mironovich S; Dzeranova A; Lyan E
    BMC Cardiovasc Disord; 2017 Jun; 17(1):171. PubMed ID: 28662693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Kinetics of Activated Clotting Time Among Uninterrupted Oral Anticoagulants During Catheter Ablation Procedure.
    Kawaji T; Morimoto T; Aizawa T; Hojo S; Kushiyama A; Yaku H; Nakatsuma K; Kaneda K; Kato M; Yokomatsu T; Miki S; Kimura T
    J Clin Pharmacol; 2022 Jun; 62(6):792-800. PubMed ID: 34921561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of uninterrupted low-intensity warfarin for cryoballoon ablation of atrial fibrillation in the elderly: A pilot study.
    Xing Y; Xu B; Sheng X; Xu C; Peng F; Sun Y; Wang S; Guo H
    J Clin Pharm Ther; 2018 Jun; 43(3):401-407. PubMed ID: 29484682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter ablation of left atrial arrhythmias on uninterrupted oral anticoagulation with vitamin K antagonists: What is the relationship between international normalized ratio, activated clotting time, and procedure-related complications?
    Kottmaier M; Bourier F; Semmler V; Telishevska M; Koch-Büttner K; Lennerz C; Lengauer S; Kornmayer M; Rousseva E; Brooks S; Brkic A; Grebmer C; Kolb C; Hessling G; Deisenhofer I; Reents T
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1415-1422. PubMed ID: 28800176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.
    Hohnloser SH; Camm J; Cappato R; Diener HC; Heidbuchel H; Lanz HJ; Mont L; Morillo CA; Smolnik R; Yin OQP; Kautzner J
    Clin Cardiol; 2018 Apr; 41(4):440-449. PubMed ID: 29663464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is transesophageal echocardiogram mandatory in patients undergoing ablation of atrial fibrillation with uninterrupted novel oral anticoagulants? Results from a prospective multicenter registry.
    Di Biase L; Briceno DF; Trivedi C; Mohanty S; Gianni C; Burkhardt JD; Mohanty P; Bai R; Gunda S; Horton R; Bailey S; Sanchez JE; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Reddy YM; Zagrodzky J; Hongo R; Beheiry S; Lakkireddy D; Natale A
    Heart Rhythm; 2016 Jun; 13(6):1197-202. PubMed ID: 26994940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Uninterrupted Low-Intensity Warfarin for Radiofrequency Catheter Ablation of Atrial Fibrillation in the Elderly.
    Xing Y; Xu B; Xu C; Peng F; Yang B; Qiu Y; Sun Y; Wang S; Guo H
    Ann Pharmacother; 2017 Sep; 51(9):735-742. PubMed ID: 28573932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance?
    Page SP; Siddiqui MS; Finlay M; Hunter RJ; Abrams DJ; Dhinoja M; Earley MJ; Sporton SC; Schilling RJ
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):265-70. PubMed ID: 21040095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and safety of uninterrupted apixaban in patients undergoing radiofrequency ablation for atrial fibrillation.
    Osaka Y; Ono Y; Tao S; Goto K; Miyazaki T; Suzuki A; Kurihara K; Otomo K; Hirao K
    J Interv Card Electrophysiol; 2020 Jun; 58(1):35-41. PubMed ID: 31104262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
    Calkins H; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Serota H; Nordaby M; Guiver K; Biss B; Brouwer MA; Grimaldi M;
    N Engl J Med; 2017 Apr; 376(17):1627-1636. PubMed ID: 28317415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.